Integral Diagnostics (ASX:IDX) reports its full-year operating net profit after tax (NPAT) at A$17.8 million, down from A$21.7 million from the previous year.
The company declares a final dividend of 6 Australian cents per share.
Additionally, its full-year statutory revenue noted an increase of 22.1%, reaching A$440.8 million.
Integral Diagnostics is a healthcare company that offers diagnostic imaging services.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
